Neolife SA (France) Performance
| ALNLF Stock | EUR 0.06 0.0009 1.45% |
The company secures a Beta (Market Risk) of 0.0545, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Neolife SA's returns are expected to increase less than the market. However, during the bear market, the loss of holding Neolife SA is expected to be smaller as well. Neolife SA right now secures a risk of 2.81%. Please verify Neolife SA sortino ratio, skewness, period momentum indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Neolife SA will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Neolife SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Neolife SA is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors. ...more
| Begin Period Cash Flow | 3.3 M | |
| Total Cashflows From Investing Activities | -840.9 K |
Neolife |
Neolife SA Relative Risk vs. Return Landscape
If you would invest 6.30 in Neolife SA on September 25, 2024 and sell it today you would lose (0.10) from holding Neolife SA or give up 1.59% of portfolio value over 90 days. Neolife SA is generating 0.0134% of daily returns and assumes 2.813% volatility on return distribution over the 90 days horizon. Simply put, 25% of stocks are less volatile than Neolife, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Neolife SA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Neolife SA's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Neolife SA, and traders can use it to determine the average amount a Neolife SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0048
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ALNLF |
Estimated Market Risk
| 2.81 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.01 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Neolife SA is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neolife SA by adding Neolife SA to a well-diversified portfolio.
Neolife SA Fundamentals Growth
Neolife Stock prices reflect investors' perceptions of the future prospects and financial health of Neolife SA, and Neolife SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Neolife Stock performance.
| Return On Equity | -0.33 | |||
| Return On Asset | -0.0484 | |||
| Profit Margin | (0.05) % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 3.6 M | |||
| Shares Outstanding | 52.38 M | |||
| Price To Book | 1.28 X | |||
| Price To Sales | 0.18 X | |||
| Revenue | 10.72 M | |||
| EBITDA | 574.66 K | |||
| Cash And Equivalents | 691.45 K | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 1.93 M | |||
| Debt To Equity | 123.90 % | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (94.41 K) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 6.22 M | |||
About Neolife SA Performance
Assessing Neolife SA's fundamental ratios provides investors with valuable insights into Neolife SA's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Neolife SA is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Its solutions enable architects, landscapists, design offices, and building technicians to meet environmental specification packages for HQE , BREEAM, and LEED projects for individual and multi-unit housing, commercial buildings, and urban spaces. The company was incorporated in 2012 and is headquartered in Limonest, France. Neolife SA is traded on Paris Stock Exchange in France.Things to note about Neolife SA performance evaluation
Checking the ongoing alerts about Neolife SA for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Neolife SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Neolife SA has some characteristics of a very speculative penny stock | |
| Neolife SA has high likelihood to experience some financial distress in the next 2 years | |
| Neolife SA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 10.72 M. Net Loss for the year was (169.34 K) with profit before overhead, payroll, taxes, and interest of 3.43 M. | |
| Neolife SA has accumulated about 691.45 K in cash with (94.41 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. |
- Analyzing Neolife SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Neolife SA's stock is overvalued or undervalued compared to its peers.
- Examining Neolife SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Neolife SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Neolife SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Neolife SA's stock. These opinions can provide insight into Neolife SA's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Neolife Stock Analysis
When running Neolife SA's price analysis, check to measure Neolife SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neolife SA is operating at the current time. Most of Neolife SA's value examination focuses on studying past and present price action to predict the probability of Neolife SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neolife SA's price. Additionally, you may evaluate how the addition of Neolife SA to your portfolios can decrease your overall portfolio volatility.